Repairing full-thickness skin defects
is a major challenge in clinical
practice. Three-dimensional (3D) bioprinting of living cells and biomaterials
is a promising technique to resolve this challenge. However, the time-consuming
preparation and limited sources of biomaterials are bottlenecks that
must be addressed. Therefore, we developed a simple and fast method
to directly process adipose tissue into a microfragmented adipose
extracellular matrix (mFAECM) as the main component of bioink to fabricate
3D-bioprinted, biomimetic, multilayer implants. The mFAECM retained
most of the collagen and sulfated glycosaminoglycans in the native
tissue. In vitro, the mFAECM composite demonstrated biocompatibility,
printability, and fidelity and could support cell adhesion. In a full-thickness
skin defect model in nude mice, cells encapsulated in the implant
survived and participated in wound repair after implantation. The
basic structures of the implant were maintained throughout wound healing
and gradually metabolized. The biomimetic multilayer implants fabricated
via mFAECM composite bioinks and cells could accelerate wound healing
by promoting the contraction of new tissue inside the wound, collagen
secretion and remodeling, and neovascularization. This study provides
an approach for improving the timeliness of fabricating 3D-bioprinted
skin substitutes and may offer a useful tool for treating full-thickness
skin defects.